{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:16Z","timestamp":1793157916016,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["24ZR1408900"],"award-info":[{"award-number":["24ZR1408900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22H160016"],"award-info":[{"award-number":["LY22H160016"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.1038\/s41388-026-03710-2","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:42:20Z","timestamp":1772109740000},"page":"1161-1174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CDK8 phosphorylates SOX2 to maintain stemness of pituitary adenoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Yilin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-9180","authenticated-orcid":false,"given":"Hongying","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-7907","authenticated-orcid":false,"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-3993","authenticated-orcid":false,"given":"Zhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"3710_CR1","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.5444","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos NA, Miller KK. Diagnosis and management of pituitary adenomas: a review. JAMA. 2023;329:1386\u201398.","journal-title":"JAMA"},{"key":"3710_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516\u201324.","journal-title":"JAMA"},{"key":"3710_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382:937\u201350.","journal-title":"N Engl J Med"},{"key":"3710_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1530\/EJE-16-0979","volume":"176","author":"H Lasolle","year":"2017","unstructured":"Lasolle H, Cortet C, Castinetti F, Cloix L, Caron P, Delemer B, et al. Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. Eur J Endocrinol. 2017;176:769\u201377.","journal-title":"Eur J Endocrinol"},{"key":"3710_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41574-021-00514-0","volume":"17","author":"E Peverelli","year":"2021","unstructured":"Peverelli E, Treppiedi D, Mangili F, Catalano R, Spada A, Mantovani G. Drug resistance in pituitary tumours: from cell membrane to intracellular signalling. Nat Rev Endocrinol. 2021;17:560\u201371.","journal-title":"Nat Rev Endocrinol"},{"key":"3710_CR6","doi-asserted-by":"crossref","unstructured":"Gaspar LM, Goncalves CI, Fonseca F, Carvalho D, Cortez L, Palha A, et al. A common variant in the CDK8 gene is associated with sporadic pituitary adenomas in the Portuguese population: a case-control study. Int J Mol Sci 2022;23:11749.","DOI":"10.3390\/ijms231911749"},{"key":"3710_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ng.3322","volume":"47","author":"Z Ye","year":"2015","unstructured":"Ye Z, Li Z, Wang Y, Mao Y, Shen M, Zhang Q, et al. Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma. Nat Genet. 2015;47:793\u20137.","journal-title":"Nat Genet"},{"key":"3710_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2014.06.036","volume":"158","author":"KL Tsai","year":"2014","unstructured":"Tsai KL, Tomomori-Sato C, Sato S, Conaway RC, Conaway JW, Asturias FJ. Subunit architecture and functional modular rearrangements of the transcriptional mediator complex. Cell. 2014;158:463.","journal-title":"Cell"},{"key":"3710_CR9","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912\u201334.","journal-title":"Science"},{"key":"3710_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature07179","volume":"455","author":"R Firestein","year":"2008","unstructured":"Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008;455:547\u201351.","journal-title":"Nature"},{"key":"3710_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2004.10.014","volume":"16","author":"CJ Fryer","year":"2004","unstructured":"Fryer CJ, White JB, Jones KA. Mastermind recruits CycC: CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell. 2004;16:509\u201320.","journal-title":"Mol Cell"},{"key":"3710_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","volume":"139","author":"C Alarcon","year":"2009","unstructured":"Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell. 2009;139:757\u201369.","journal-title":"Cell"},{"key":"3710_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","volume":"38","author":"J Bancerek","year":"2013","unstructured":"Bancerek J, Poss ZC, Steinparzer I, Sedlyarov V, Pfaffenwimmer T, Mikulic I, et al. CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity. 2013;38:250\u201362.","journal-title":"Immunity"},{"key":"3710_CR14","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nature09590","volume":"468","author":"A Kapoor","year":"2010","unstructured":"Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature. 2010;468:1105\u20139.","journal-title":"Nature"},{"key":"3710_CR15","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41388-021-01745-1","volume":"40","author":"K Fukasawa","year":"2021","unstructured":"Fukasawa K, Kadota T, Horie T, Tokumura K, Terada R, Kitaguchi Y, et al. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway. Oncogene. 2021;40:2803\u201315.","journal-title":"Oncogene"},{"key":"3710_CR16","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1158\/0008-5472.CAN-11-3886","volume":"72","author":"AS Adler","year":"2012","unstructured":"Adler AS, McCleland ML, Truong T, Lau S, Modrusan Z, Soukup TM, et al. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res. 2012;72:2129\u201339.","journal-title":"Cancer Res"},{"key":"3710_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/ERC-14-0546","volume":"22","author":"F Mertens","year":"2015","unstructured":"Mertens F, Gremeaux L, Chen J, Fu Q, Willems C, Roose H, et al. Pituitary tumors contain a side population with tumor stem cell-associated characteristics. Endocr Relat Cancer. 2015;22:481\u2013504.","journal-title":"Endocr Relat Cancer"},{"key":"3710_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cgt.2014.63","volume":"22","author":"M Orciani","year":"2015","unstructured":"Orciani M, Davis S, Appolloni G, Lazzarini R, Mattioli-Belmonte M, Ricciuti RA, et al. Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. Cancer Gene Ther. 2015;22:9\u201316.","journal-title":"Cancer Gene Ther"},{"key":"3710_CR19","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s12035-016-0025-x","volume":"54","author":"R Wurth","year":"2017","unstructured":"Wurth R, Barbieri F, Pattarozzi A, Gaudenzi G, Gatto F, Fiaschi P, et al. Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas. Mol Neurobiol. 2017;54:4879\u201395.","journal-title":"Mol Neurobiol"},{"key":"3710_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.bjc.6605142","volume":"101","author":"Q Xu","year":"2009","unstructured":"Xu Q, Yuan X, Tunici P, Liu G, Fan X, Xu M, et al. Isolation of tumour stem-like cells from benign tumours. Br J Cancer. 2009;101:303\u201311.","journal-title":"Br J Cancer"},{"key":"3710_CR21","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/neuonc\/nor113","volume":"13","author":"D Hagerstrand","year":"2011","unstructured":"Hagerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, et al. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol. 2011;13:1178\u201391.","journal-title":"Neuro Oncol"},{"key":"3710_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2014.05.005","volume":"26","author":"RJ Vanner","year":"2014","unstructured":"Vanner RJ, Remke M, Gallo M, Selvadurai HJ, Coutinho F, Lee L, et al. Quiescent Sox2 (+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell. 2014;26:33\u201347.","journal-title":"Cancer Cell"},{"key":"3710_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccr.2014.01.008","volume":"25","author":"V Justilien","year":"2014","unstructured":"Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR, Fields AP. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell. 2014;25:139\u201351.","journal-title":"Cancer Cell"},{"key":"3710_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","volume":"67","author":"D Novak","year":"2020","unstructured":"Novak D, Huser L, Elton JJ, Umansky V, Altevogt P, Utikal J. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67:74\u201382.","journal-title":"Semin Cancer Biol"},{"key":"3710_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2013.07.004","volume":"13","author":"CL Andoniadou","year":"2013","unstructured":"Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, et al. Sox2(+) stem\/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell. 2013;13:433\u201345.","journal-title":"Cell Stem Cell"},{"key":"3710_CR26","doi-asserted-by":"crossref","unstructured":"Lodge EJ, Santambrogio A, Russell JP, Xekouki P, Jacques TS, Johnson RL, et al. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS\/YAP\/TAZ cascade. Elife 2019;8:e43996.","DOI":"10.7554\/eLife.43996"},{"key":"3710_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.stem.2011.10.004","volume":"9","author":"B Biteau","year":"2011","unstructured":"Biteau B, Hochmuth CE, Jasper H. Maintaining tissue homeostasis: dynamic control of somatic stem cell activity. Cell Stem Cell. 2011;9:402\u201311.","journal-title":"Cell Stem Cell"},{"key":"3710_CR28","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1210\/en.2012-1152","volume":"153","author":"Q Fu","year":"2012","unstructured":"Fu Q, Gremeaux L, Luque RM, Liekens D, Chen J, Buch T, et al. The adult pituitary shows stem\/progenitor cell activation in response to injury and is capable of regeneration. Endocrinology. 2012;153:3224\u201335.","journal-title":"Endocrinology"},{"key":"3710_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stem.2013.07.006","volume":"13","author":"K Rizzoti","year":"2013","unstructured":"Rizzoti K, Akiyama H, Lovell-Badge R. Mobilized adult pituitary stem cells contribute to endocrine regeneration in response to physiological demand. Cell Stem Cell. 2013;13:419\u201332.","journal-title":"Cell Stem Cell"},{"key":"3710_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/74199","volume":"24","author":"H Niwa","year":"2000","unstructured":"Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3\/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372\u20136.","journal-title":"Nat Genet"},{"key":"3710_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.molcel.2014.06.018","volume":"55","author":"L Fang","year":"2014","unstructured":"Fang L, Zhang L, Wei W, Jin X, Wang P, Tong Y, et al. A methylation-phosphorylation switch determines Sox2 stability and function in ESC maintenance or differentiation. Mol Cell. 2014;55:537\u201351.","journal-title":"Mol Cell"},{"key":"3710_CR32","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1038\/s41388-019-0790-x","volume":"38","author":"Z Wang","year":"2019","unstructured":"Wang Z, Kang L, Zhang H, Huang Y, Fang L, Li M, et al. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation. Oncogene. 2019;38:5250\u201364.","journal-title":"Oncogene"},{"key":"3710_CR33","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41388-023-02748-w","volume":"42","author":"L Kang","year":"2023","unstructured":"Kang L, Liu Y, He J, Wang Y, Xue M, Wu X, et al. GSK3beta-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma. Oncogene. 2023;42:2297\u2013314.","journal-title":"Oncogene"},{"key":"3710_CR34","doi-asserted-by":"crossref","unstructured":"Fang X, Huang Z, Zhai K, Huang Q, Tao W, Kim L, et al. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice. Sci Transl Med 2021;13:eabc7275.","DOI":"10.1126\/scitranslmed.abc7275"},{"key":"3710_CR35","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1158\/0008-5472.CAN-18-0330","volume":"78","author":"D Ravindran Menon","year":"2018","unstructured":"Ravindran Menon D, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, et al. CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma. Cancer Res. 2018;78:6561\u201374.","journal-title":"Cancer Res"},{"key":"3710_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.stem.2009.05.021","volume":"5","author":"D Van Hoof","year":"2009","unstructured":"Van Hoof D, Munoz J, Braam SR, Pinkse MW, Linding R, Heck AJ, et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell. 2009;5:214\u201326.","journal-title":"Cell Stem Cell"},{"key":"3710_CR37","doi-asserted-by":"publisher","first-page":"22782","DOI":"10.1074\/jbc.M115.658195","volume":"290","author":"J Ouyang","year":"2015","unstructured":"Ouyang J, Yu W, Liu J, Zhang N, Florens L, Chen J, et al. Cyclin-dependent kinase-mediated Sox2 phosphorylation enhances the ability of Sox2 to establish the pluripotent state. J Biol Chem. 2015;290:22782\u201394.","journal-title":"J Biol Chem"},{"key":"3710_CR38","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.7150\/thno.21717","volume":"8","author":"J Ji","year":"2018","unstructured":"Ji J, Yu Y, Li ZL, Chen MY, Deng R, Huang X, et al. XIAP limits autophagic degradation of Sox2 and is a therapeutic target in nasopharyngeal carcinoma stem cells. Theranostics. 2018;8:1494\u2013510.","journal-title":"Theranostics"},{"key":"3710_CR39","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41388-023-02745-z","volume":"42","author":"L Kang","year":"2023","unstructured":"Kang L, Zhang H, Wang Y, Chu M, He J, Xue M, et al. Control of SOX2 protein stability and tumorigenic activity by E3 ligase CHIP in esophageal cancer cells. Oncogene. 2023;42:2315\u201328.","journal-title":"Oncogene"},{"key":"3710_CR40","unstructured":"WHO Classification of Tumours Editorial Board (eds). Endocrine and Neuroendocrine Tumours. WHO Classification of Tumours, 5th ed., Vol. 10. IARC Publications, Lyon, 2025."},{"key":"3710_CR41","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41422-022-00736-5","volume":"32","author":"F Zhang","year":"2022","unstructured":"Zhang F, Zhang Q, Zhu J, Yao B, Ma C, Qiao N, et al. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. Cell Res. 2022;32:1047\u201367.","journal-title":"Cell Res"},{"key":"3710_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-016-0394-4","volume":"4","author":"B Manoranjan","year":"2016","unstructured":"Manoranjan B, Mahendram S, Almenawer SA, Venugopal C, McFarlane N, Hallett R, et al. The identification of human pituitary adenoma-initiating cells. Acta Neuropathol Commun. 2016;4:125.","journal-title":"Acta Neuropathol Commun"},{"key":"3710_CR43","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-19-0789","volume":"19","author":"MH Hofmann","year":"2020","unstructured":"Hofmann MH, Mani R, Engelhardt H, Impagnatiello MA, Carotta S, Kerenyi M, et al. Selective and potent CDK8\/19 inhibitors enhance NK-cell activity and promote tumor surveillance. Mol Cancer Ther. 2020;19:1018\u201330.","journal-title":"Mol Cancer Ther"},{"key":"3710_CR44","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/neuonc\/noab137","volume":"23","author":"JE Eckel-Passow","year":"2021","unstructured":"Eckel-Passow JE, Kitange GJ, Decker PA, Kosel ML, Burgenske DM, Oberg AL, et al. Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX lines. Neuro Oncol. 2021;23:2066\u201375.","journal-title":"Neuro Oncol"},{"key":"3710_CR45","first-page":"617","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33:617\u20138.","journal-title":"Neurosurgery"},{"key":"3710_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/cdd.2015.106","volume":"23","author":"J Wang","year":"2016","unstructured":"Wang J, Zhang Y, Hou J, Qian X, Zhang H, Zhang Z, et al. Ube2s regulates Sox2 stability and mouse ES cell maintenance. Cell Death Differ. 2016;23:393\u2013404.","journal-title":"Cell Death Differ"},{"key":"3710_CR47","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1080\/15548627.2017.1328347","volume":"13","author":"ZG Leng","year":"2017","unstructured":"Leng ZG, Lin SJ, Wu ZR, Guo YH, Cai L, Shang HB, et al. Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy. 2017;13:1404\u201319.","journal-title":"Autophagy"},{"key":"3710_CR48","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1210\/jc.2017-00627","volume":"102","author":"SJ Lin","year":"2017","unstructured":"Lin SJ, Wu ZR, Cao L, Zhang Y, Leng ZG, Guo YH, et al. Pituitary tumor suppression by a combination of cabergoline and chloroquine. J Clin Endocrinol Metab. 2017;102:3692\u2013703.","journal-title":"J Clin Endocrinol Metab"},{"key":"3710_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-024-03020-z","volume":"43","author":"S Schneegans","year":"2024","unstructured":"Schneegans S, Loptien J, Mojzisch A, Loreth D, Kretz O, Raschdorf C, et al. HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis. J Exp Clin Cancer Res. 2024;43:110.","journal-title":"J Exp Clin Cancer Res"},{"key":"3710_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-020-00242-3","volume":"5","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xiong X, Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020;5:135.","journal-title":"Signal Transduct Target Ther"},{"key":"3710_CR51","unstructured":"Study of BCD-115 in women with ER(+) HER2(\u2013) local advanced and metastatic breast cancer: https:\/\/clinicaltrials.gov\/study\/NCT03065010 2018."},{"key":"3710_CR52","unstructured":"RVU120 in patients with intermediate or high-risk, primary or secondary myelofibrosis (POTAMI-61): https:\/\/clinicaltrials.gov\/study\/NCT06397313 2025."},{"key":"3710_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11102-019-01003-4","volume":"23","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Cui W, Zhu D, Gao N, Zhu Y. Common tools for pituitary adenomas research: cell lines and primary cells. Pituitary. 2020;23:182\u20138.","journal-title":"Pituitary"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03710-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03710-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03710-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:13:05Z","timestamp":1774307585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03710-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":53,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,4,14]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03710-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article the affiliation details for Zerui Wu were incorrectly given as 'Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China' and 'Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China', but should have been solely 'Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China'.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}